Review
Published on 26 Oct 2020
P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.576559
- 37,871 views
- 125 citations
Type at least 3 characters
1,011 articles
Articles
Original Research
Published on 26 Oct 2020
Costunolide Induces Autophagy and Apoptosis by Activating ROS/MAPK Signaling Pathways in Renal Cell Carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.582273
- 4,312 views
- 30 citations
Original Research
Published on 22 Oct 2020
Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.552907
- 5,301 views
- 52 citations
Original Research
Published on 22 Oct 2020
Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.532292
- 5,145 views
- 7 citations
Case Report
Published on 22 Oct 2020
Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.558572
- 4,422 views
- 14 citations
Original Research
Published on 19 Oct 2020
Manganese-Based Targeted Nanoparticles for Postoperative Gastric Cancer Monitoring via Magnetic Resonance Imaging
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.601538
- 3,083 views
- 6 citations
Original Research
Published on 19 Oct 2020
Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.562196
- 8,871 views
- 29 citations
Original Research
Published on 16 Oct 2020
The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.558414
- 5,939 views
- 36 citations
Original Research
Published on 15 Oct 2020
Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor
in Pharmacology of Anti-Cancer Drugs
![Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor](https://www.frontiersin.org/files/myhome article library/592385/592385_Thumb_400.jpg)
Frontiers in Oncology
doi 10.3389/fonc.2020.592385
- 2,603 views
- 7 citations
Original Research
Published on 06 Oct 2020
Sub-acute Toxicity Assessment of Taxol Isolated From Fusarium Solani, an Endophytic Fungus of Taxus Brevifolia, in Wistar Rats and Analyzing Its Cytotoxicity and Apoptotic Potential in Lung Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.538865
- 3,188 views
- 7 citations
Case Report
Published on 02 Oct 2020
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.559057
- 2,971 views
- 2 citations
Original Research
Published on 30 Sep 2020
Baoyuan Jiedu Decoction Alleviates Cancer-Induced Myotube Atrophy by Regulating Mitochondrial Dynamics Through p38 MAPK/PGC-1α Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.523577
- 4,053 views
- 9 citations
Original Research
Published on 30 Sep 2020
Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.532285
- 6,606 views
- 28 citations
Perspective
Published on 11 Sep 2020
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01699
- 4,007 views
- 13 citations
Brief Research Report
Published on 11 Sep 2020
Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.540030
- 1,901 views
- 6 citations
Original Research
Published on 10 Sep 2020
RETRACTED: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01756
- 4,241 views
- 12 citations